Genotyping for epidemiology studies
流行病学研究的基因分型
基本信息
- 批准号:10199835
- 负责人:
- 金额:$ 56.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-31 至 2020-08-30
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAcute Myelocytic LeukemiaAdenocarcinomaAplastic AnemiaAreaBasic ScienceBiological AssayBurkitt LymphomaCOVID-19CaringCervical Cancer ScreeningChronic Lymphocytic LeukemiaColorectal CancerCommunitiesCustomDNADataData AnalysesData SetData Storage and RetrievalDevelopmentDiseaseDisease OutcomeDivision of Cancer Epidemiology and GeneticsEmploymentEndometrial CarcinomaEnvironmental Risk FactorEpidemiologistEwings sarcomaExperimental DesignsFanconi&aposs AnemiaGenerationsGenesGeneticGenetic MarkersGenetic VariationGenome ScanGenomicsGenotypeHelicobacter pyloriHeritabilityHodgkin DiseaseHumanHuman GeneticsHuman GenomeHuman PapillomavirusImageImmunohistochemistryIndividualInfectionInformaticsInformation ManagementIntramural Research ProgramLaboratoriesLaboratory ResearchLi-Fraumeni SyndromeMalignant NeoplasmsMalignant neoplasm of esophagusMalignant neoplasm of lungMalignant neoplasm of ovaryMalignant neoplasm of pancreasMalignant neoplasm of pituitary glandMalignant neoplasm of prostateMalignant neoplasm of thyroidMeta-AnalysisMolecular EpidemiologyMyelofibrosisMyotonic DystrophyNeurofibromatosis 1Non-Hodgkin&aposs LymphomaNormal tissue morphologyNucleic AcidsOutcomePatientsPhenotypePredispositionProteomicsPublicationsPublishingRenal carcinomaResearchResearch PersonnelResearch SupportResourcesRhabdomyosarcomaSamplingScientific Advances and AccomplishmentsScientistSpecimenStatistical MethodsSupport GroupsSurveysTechniquesTechnologyTechnology TransferTissuesWaldenstrom MacroglobulinemiaWorkanticancer researchbioinformatics pipelinecancer genomicscostcost effectivedata accessdata resourcedatabase of Genotypes and Phenotypesdesigndigitaldigital pathologyepidemiology studyexome sequencingfollow-upgenetic variantgenome sequencinggenome wide association studygenome-widehuman genome sequencinghuman genomicsinterestlarge datasetsmalignant breast neoplasmmelanomamicrobiome sequencingmolecular pathologynovelosteosarcomatechnology research and developmenttissue processingtooltumor
项目摘要
The Cancer Genomics Research (CGR) Laboratory was established to investigate the contribution of genetic variation to cancer susceptibility and outcomes. Working in concert with epidemiologists, biostatisticians, and basic research scientists in DCEG’s intramural research program, the CGR provides the capacity to conduct genome-wide discovery studies and targeted regional approaches to identify the heritable determinants of various forms of cancer. New work has begun in somatic research with the use of tumor/normal tissue nucleic acids for cross-platform comparisons in subjects of interest. A support group for molecular and digital pathology research within CGR has been added to support these efforts. CGR supports DCEG in all stages of cancer research from planning to publishing, including experimental design and project management, sample handling, genotyping and sequencing assay design and execution, tissue research support, development and implementation of bioinformatic pipelines, and downstream research and analytical support. These factors make CGR a unique collaborative center for NCI-driven scientific endeavors.
癌症基因组学研究 (CGR) 实验室的成立是为了研究遗传变异对癌症易感性和结果的影响,CGR 与 DCEG 校内研究项目中的流行病学家、生物统计学家和基础研究科学家合作,提供了进行基因组研究的能力。广泛的发现研究和有针对性的区域方法来确定各种形式癌症的遗传决定因素,在体细胞研究中已经开始使用肿瘤/正常组织核酸进行跨平台比较。 CGR 内增加了一个分子和数字病理学研究支持小组,以支持从规划到发布的癌症研究各个阶段的 DCEG 检测,包括实验设计和项目管理、样本处理、基因分型和测序设计。这些因素使 CGR 成为 NCI 驱动的科学事业的独特合作中心。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ethan Dmitrovsky其他文献
Ethan Dmitrovsky的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ethan Dmitrovsky', 18)}}的其他基金
DCEG- Molecular Assays for epidemiology studies
DCEG-流行病学研究的分子测定
- 批准号:
10199837 - 财政年份:2019
- 资助金额:
$ 56.53万 - 项目类别:
相似国自然基金
NMNAT1上调B7-H3介导急性早幼粒细胞白血病免疫逃逸的作用和机制研究
- 批准号:82300169
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PML-RARα远程调控组织因子的表达在急性早幼粒细胞白血病发生致死性出血的机制探究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
STING介导IFN信号通路参与TBLR1-RARα急性早幼粒细胞白血病发生发展及耐药的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
干扰素诱导基因IFIT1/IFIT3在氯碘羟喹诱导急性粒细胞白血病细胞焦亡中的作用和机制
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
复方黄黛片通过激活TNF-α/RIPK1/MLKL通路促进急性早幼粒细胞白血病坏死性凋亡的机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
University of Pennsylvania Patient-derived Xenograft Development and Trials Center
宾夕法尼亚大学患者来源的异种移植开发和试验中心
- 批准号:
10733231 - 财政年份:2023
- 资助金额:
$ 56.53万 - 项目类别:
The role of DPF2 stability in SMARCB1-deficient cancers
DPF2 稳定性在 SMARCB1 缺陷型癌症中的作用
- 批准号:
10751414 - 财政年份:2023
- 资助金额:
$ 56.53万 - 项目类别:
Discovery of First-in-class WDR5 PROTACs as a Novel Therapeutic Strategy for MLL-rearranged Leukemias
发现一流的 WDR5 PROTAC 作为 MLL 重排白血病的新型治疗策略
- 批准号:
10712396 - 财政年份:2022
- 资助金额:
$ 56.53万 - 项目类别:
Mechanism-based targeting of unique survival signaling in residual tumors
基于机制的残留肿瘤中独特生存信号的靶向
- 批准号:
10442812 - 财政年份:2022
- 资助金额:
$ 56.53万 - 项目类别:
Mechanism-based targeting of unique survival signaling in residual tumors
基于机制的残留肿瘤中独特生存信号的靶向
- 批准号:
10595654 - 财政年份:2022
- 资助金额:
$ 56.53万 - 项目类别: